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Introduction
Venous oxygen saturation is a clinical tool which inte-
grates the whole body oxygen uptake-to-delivery (VO2-
DO2) relationship. In the clinical setting, in the absence 
of pulmonary artery catheter (PAC)-derived mixed 
venous oxygen saturation (SvO2), the central venous 
oxygen saturation (ScvO2) is increasingly being used as a 
reasonably accurate surrogate [1]. Central venous catheters 
(CVCs) are simpler to insert, and generally safer and 
cheaper than PACs. Th   e CVC allows sampling of blood 
for measurement of ScvO2 or even continuous monitor-
ing if an oximetry catheter is being used. Th  e normal 
range for SvO2 is 68 to 77% and ScvO2 is considered to be 
5% above these values [2].
A decrease in hemoglobin (Hb, g/dl) is likely to be 
associated with a decrease in DO2 when cardiac output 
(CO) remains unchanged, since DO2 = CO x CaO2, where 
CaO2 is arterial oxygen content and is ≈ Hb × SaO2 x 1.34 
(where SaO2 is the arterial oxygen saturation in%; and 
1.34 is the oxygen-carrying capacity of Hb in mlO2/g Hb), 
when one ignores the negligible oxygen not bound to Hb 
[1]. A decrease in Hb is one of the four determinants 
responsible for a decrease in SvO2 (or ScvO2), alone or in 
combination with hypoxemia (decrease in SaO2), an 
increase in VO2 without a concomitant increase in DO2, 
or a fall in cardiac output.
When DO2 decreases, VO2 is maintained (at least 
initially) by an increase in oxygen extraction (O2ER) since 
O2ER = VO2/DO2. As VO2 ≈ (SaO2 – SvO2) × (Hb × 1.34 × 
CO) and DO2 ≈ SaO2 × Hb × 1.34 × CO, O2ER and SvO2
are thus linked by a simple equation: O2ER ≈ (SaO2 – 
SvO2)/SaO2 or even simpler: O2ER ≈ 1 – SvO2. Assuming 
SaO2 = 1 [3], if SvO2 is 40%, then O2ER is 60%.
Because it integrates Hb, cardiac output, VO2 and SaO2, 
the venous oxygen saturation therefore helps to assess 
the VO2-DO2 relationship and tolerance to anemia during 
blood loss.
Venous oxygen saturation as a physiologic 
transfusion trigger
When DO2 decreases beyond a certain threshold, it 
induces a decrease in VO2. Th  is point is known as the 
critical DO2 (DO2crit), below which there is a state of 
VO2-DO2 dependency also called tissue dysoxia. In 
humans, dysoxia is usually present when SvO2 falls below 
a critical 40–50% (SvO2crit); this may, however, also 
occur at higher levels of SvO2 when O2ER is impaired. 
Usually eﬀ  orts in correcting cardiac output (by ﬂ  uids or 
inotropes), and/or Hb and/or SaO2 and/or VO2 must 
target a return of SvO2 (ScvO2) from 50 to 65–70% [4]. In 
sedated critically ill patients in whom life support was 
discontinued, the DO2crit was found to be approximately 
3.8 to 4.5 mlO2/kg/min for a VO2 of about 2.4 mlO2/g/
min; O2ER reached an O2ERcrit of 60% [5] with SvO2crit 
being ≈ 40%.
In a landmark study by Rivers et al. [6], patients 
admitted to an emergency department with severe sepsis 
and septic shock were randomized to standard therapy 
(aiming for a central venous pressure [CVP] of 8–12 mmHg, 
mean arterial pressure (MAP) ≥  65  mmHg, and urine 
output ≥ 0.5 ml/kg/h) or to early goal-directed therapy 
where, in addition to the previous parameters, an ScvO2
of at least 70% was targeted by optimizing ﬂ  uid 
administration, keeping hematocrit ≥ 30%, and/or giving 
dobutamine to a maximum of 20 μg/kg/min. Th  e  initial 
ScvO2 in both groups was low (49 ± 12%), suggesting a 
hypodynamic condition before resuscitation was started. 
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was signiﬁ  cantly larger in the early goal-directed therapy 
patients (≈ 5,000 ml vs 3,500 ml, p < 0.001), fewer patients 
in the early goal-directed therapy group received vaso-
pressors (27.4 vs 30.3%, p = NS), and signiﬁ  cantly more 
patients were treated with dobutamine (13.7 vs 0.8%, 
p < 0.001). It is noticeable that the number of patients 
receiving red blood cells (RBCs) was signiﬁ  cantly larger 
in the early goal-directed therapy group than in the 
control group (64.1 vs 18.5%) suggesting that the strategy 
of targeting a ScvO2 of at least 70% was associated with 
more decisions to transfuse once ﬂ  uid, vasopressors, and 
dobutamine had been titrated to improve tissue oxygena-
tion. In the follow-up period between the 7th and the 72nd 
hour, mean ScvO2 was higher, mean arterial pH was 
higher, and plasma lactate levels and base excess were 
lower in patients who received early goal-directed therapy. 
Organ failure score and mortality were signiﬁ  cantly 
diﬀ  erent in patients receiving standard therapy compared 
to early goal-directed therapy patients. Th   is was the ﬁ  rst 
study to demonstrate that initiation of early goal-directed 
therapy to achieve an adequate level of tissue oxygenation 
by DO2 (as judged by ScvO2 monitoring) could signiﬁ  -
cantly reduce mortality.
In a prospective observational study [7], we tested how 
well the ScvO2 corresponded to the French recom  men-
dations for blood transfusion and to the anesthesiologist’s 
decision to transfuse. Th  e French recommendations for 
blood transfusion were presented during a consensus 
conference organized in 2003 by the French Society of 
Intensive Care Medicine (Société de Réanimation de 
Langue Française, SRLF) [8]. Th   ese recommendations are 
based on plasma Hb concentration and associated 
clinical state (Table  1), and apart from in cardiac and 
septic patients, the threshold Hb value for blood 
transfusion is 7 g/dl. Sixty high risk surgical patients in 
whom the need for a blood transfusion was discussed 
postoperatively were included in the study [7]. Th  ey  were 
eligible for study inclusion if they were hemodynamically 
stable and equipped with a CVC. Th  e decision to 
transfuse was taken by the anesthesiologist in charge of 
the patient. Th   e anesthesiologist was aware of the SRLF 
recommendations; if requested, he/she was provided 
with the ScvO2 value that was obtained at the same time 
as the blood was sampled for the Hb concentration. Th  e 
following parameters were registered: Age, a history of 
cardiovascular disease, presence of sepsis, number of 
blood units transfused, agreement with the SRLF recom-
mendations. A decision to transfuse was made in 53 of 
the 60 general and urologic surgical patients. ScvO2 and 
Hb were measured before and after blood transfusion, 
together with hemodynamic parameters (heart rate, 
systolic arterial pressure). Patients were retrospectively 
divided into two groups according to the ScvO2 before 
blood transfusion (< or ≥ 70%); each of these groups was 
further divided into two groups according to agreement 
or not with the SRLF recommendations for blood trans-
fusion. Th  e ScvO2 threshold value of 69.5% (sensitivity 
82%; speciﬁ   city 76%) was validated with a receiver 
operator characteristic (ROC) curve analysis (Figure 1).
Overall, demographic characteristics were similar (age, 
weight, number of blood units transfused) among the 
groups. Blood transfusion provided a signiﬁ  cant  and 
approxi  mately similar increase in hemoglobin concen-
tration for all patients in the four groups but the ScvO2 
value increased signiﬁ  cantly only in patients with ScvO2 
< 70% before blood transfusion (Figure 2 and Table 2). 
Figure 1. ROC curve analysis illustrating the usefulness of 
ScvO2 measurement before blood transfusion in order to 
predict a minimal 5% increase in ScvO2 after BT. The threshold 
value for ScvO2 with the best sensitivity and best specifi  city was 
69.5% (*sensitivity: 82%, specifi  city: 76%; area under the curve: 
0.831 + 0.059). Adapted from [7] with permission.
Table 1. The French recommendations for blood 
transfusion in critically ill patients are based on a 
recent consensus by the French Society of Intensive 
Care Medicine (Société de Réanimation de Langue 
Française; SRLF) using threshold values for hemoglobin 
(Hb) together with the clinical context to indicate blood 
transfusion [8].
Threshold value of Hb (g/dl)  Clinical context
10  •  Acute coronary syndrome
9  •  Ischemic heart disease
  •  Stable heart failure
8  •  Age > 75
 •  Severe  sepsis
7 •  Others
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Page 2 of 5Th   e heart rate and systolic arterial pressure did not help 
in the decision to transfuse.
Th  e conclusions of this observational study were as 
follows: 1) Twenty of the 53 patients (37.7%) received a 
blood transfusion against SRLF recommendations; 2) 
thirteen of these 20 patients (65%) had an ScvO2 < 70% 
and nevertheless seemed to beneﬁ   t from the blood 
transfusion (according to the VO2/DO2 relationship), and 
one may speculate that the fact that they did not comply 
with the SRLF recommendations for blood transfusion 
could have contributed to a “lack of blood transfusion” in 
these patients; indeed, according to the ScvO2 (which 
Figure 2. Individual evolutions in ScvO2 before and after blood transfusion (BT) according to agreement (Reco+) or not (Reco-) with the 
SRLF recommendations for transfusion and according to the ScvO2 before transfusion (< or ≥ 70%). Adapted from [7] with permission.
Table 2. Central venous O2 saturation (ScvO2), hemoglobin (Hb), heart rate (HR) and systolic arterial pressure (SAP) values 
(median [CI 95%]) in 53 hemodynamically stable postoperative patients who received blood transfusion (BT), divided 
into two groups according to their ScvO2 before blood transfusion (< or ≥ 70%); and then into four groups according to 
agreement or not with the SRLF recommendations for transfusion.
                                                  ScvO2 <70%                                                    ScvO2 ≥ 70%
SRLF         Kruskal-Wallis
recommendations  Yes (n = 15)  No (n = 13)  Yes (n = 18)  No (n = 7)  test (p <.05)
ScvO2 preBT  57.4 [48.2–62.0]  58.0 [55.3–65.0]  76.9 [72.0–80.8]  75.7 [75.0–86.4]  p < 0.001
ScvO2 postBT  68.7* [63.0–75.6]  67.8* [60.7–72.0]  78.7 [70.0–84.2]  74,0* [65.0–76.7]  p < 0.01
Hb preBT  7.4 [7.1–7.9]  7.8 [7.4–8.7]  7.5 [7.3–8.1]  8.1 [7.5–8.2]  Ns
Hb postBT  9.4** [8.7–9.7]  10.0** [9.4–10.6]  10.1** [9.3–10.6]  9.8* [9.4–10.7]  Ns
HR preBT  88 [78–90]  96 [93–120]  92 [85–105]  95 [81–112]  Ns
HR postBT  92 [84–97]  95 [89–100]  89 [78–104]  96 [78–100]  Ns
SAP preBT  118 [101–141]   130 [120–150]  128 [114–150]  130 [124–151]  Ns
SAP postBT  133 [119–140]  120 [106–140]  141* [128–161]  140* [133–175]  p = 0.047
Ns: non-signifi  cant; * p < 0.05; **p < 0.01; Wilcoxon test for values before (preBT) vs after transfusion (postBT). Adapted from [7]
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have been insuﬃ   cient (n = 2 blood units) in this sub-
group; 4) 54.5% of the patients (18/33) met the SRLF 
recommendation had an ScvO2 ≥ 70% and received a 
blood transfusion although VO2/DO2 may have been 
adequate; one may speculate that transfusion in these 
patients could have contributed to an “excess of blood 
transfusion”.
Following the study by Rivers et al. [6] and our own 
observations [7] we can conclude that ScvO2 appears to 
be an interesting parameter to help with transfusion 
decisions in hemodynamically unstable patients with 
severe sepsis or in stable high-risk surgical patients 
equipped with a CVC. ScvO2 can be proposed as a simple 
and universal physiologic transfusion trigger. Th  is 
suggestion merits a controlled randomized study in 
which patients would be separated into two treatment 
groups: 1) A control group in which the decision to 
transfuse would be made according to Hb threshold values 
(similar to those presented by the SRLF); 2) an ScvO2 goal-
directed group in which the decision to transfuse would be 
made according to an ScvO2 value < 70% as soon as the Hb 
value was less than 10 g/dl (hematocrit < 30%) providing 
that the CVP was 8 to 12 mmHg.
The concept of physiologic transfusion trigger
In an 84-year-old male Jehovah’s Witness undergoing 
profound hemodilution, the DO2crit was 4.9 mlO2/kg/
min for a VO2 of about 2.4 mlO2/kg/min; the Hb value at 
the DO2crit was 3.9 g/dl [9]. Th   is Hb value can be deﬁ  ned 
as the critical Hb value. Consistent with these results, in 
young, healthy, and conscious (which means higher VO2) 
volunteers undergoing acute hemodilution with 5% 
albumin and autologous plasma, DO2crit was found to be 
less than 7.3 mlO2/kg/min for a VO2 of 3.4 mlO2/kg/min 
[10] and an Hb value of 4.8 g/dl. Th   e same investigators 
studied healthy resting humans to test whether acute 
isovolemic reduction of blood hemoglobin concentration 
to 5 g/dl would produce an imbalance in myocardial 
oxygen supply and demand, resulting in myocardial 
ischemia [11]. Heart rate increased from 63 ± 11 (baseline 
measured before hemodilution began) to 94 ± 14 beats/
min (a mean increase of 51 ± 27%; p < 0.0001), whereas 
MAP decreased from 87 ± 10 to 76 ± 11 mmHg (a mean 
decrease of 12 ± 13%; p < 0.0001), mean diastolic blood 
pressure decreased from 67 ± 10 to 56 ± 10 mmHg 
(a mean decrease of 15 ± 16%; p < 0.0001), and mean 
systolic blood pressure decreased from 131 ± 15 to 
121 ± 16 mmHg (a mean decrease of 7 ± 11%; p = 0.0001). 
Electrocardiographic (EKG) changes were monitored 
continuously using a Holter EKG recorder for detection 
of myocardial ischemia. During hemodilution, transient, 
reversible ST-segment depression developed in three 
asymptomatic subjects at hemoglobin concentrations of 
5 g/dl. Th  e subjects who had EKG ST-segment changes 
had signiﬁ   cantly higher maximum heart rates (110 to 
140 beats/min) than those without EKG changes, despite 
having similar baseline values. Th   e higher heart rates that 
developed during hemodilution may have contributed to 
the development of an imbalance between myocardial 
oxygen supply and demand resulting in EKG evidence of 
myocardial ischemia. An approach to the myocardial 
oxygen balance is oﬀ  ered by the product systolic arterial 
pressure × heart rate which should remain below 12,000. 
For heart rate = 110 beats/min, if systolic arterial pressure is 
120 mmHg, systolic arterial pressure × heart rate = 13,200 
and may be considered too high for the myocardial VO2.
In 20 patients older than 65 years and free from known 
cardiovascular disease, Hb was decreased from 11.6 ± 0.4 
to 8.8 ± 0.3 g/dl [12]. With stable ﬁ  lling pressures, cardiac 
output increased from 2.02 ± 0.11 to 2.19 ± 0.10 l/min/m2 
(p < 0.05) while systemic vascular resistance (SVR) 
decreased from 1796 ± 136 to 1568 ± 126 dynes/s/cm5 
(p < 0.05) and O2ER increased from 28.0 ± 0.9 to 33.0 ± 0.8% 
(p < 0.05) resulting in stable VO2 during hemodilution. 
While no alterations in ST segments were observed in 
lead II, ST segment deviation became slightly less nega-
tive in lead V5 during hemodilution, from -0.03 ± 0.01 to 
-0.02 ± 0.01mV (p < 0.05). Th  e authors concluded that 
isovolemic hemodilution to a hemoglobin value of about 
8.8 g/dl was the limit that could be tolerated in these 
patients [12].
In 60 patients with coronary artery disease receiving 
chronic beta-adrenergic blocker treatment and scheduled 
for coronary artery bypass graft (CABG) surgery, Hb was 
decreased from 12.6 ± 0.2 to 9.9 ± 0.2 g/dl (p < 0.05) [13]. 
With stable ﬁ   lling pressures, cardiac output increased 
from 2.05 ± 0.05 to 2.27 ± 0.05 l/min/m2 (p < 0.05) and 
O2ER from 27.4 ± 0.6 to 31.2 ± 0.7% (p < 0.05), resulting 
in stable VO2. No alterations in ST segments were 
observed in leads II and V5 during hemodilution. Individual 
increases in cardiac index and O2ER were not linearly 
related to age or left ventricular ejection fraction [13].
Healthy young volunteers were also tested with verbal 
memory and standard computerized neuropsychologic 
tests before and twice after acute isovolemic reduction of 
their Hb concentration to 5.7 ± 0.3 g/dl [14]. Heart rate, 
MAP, and self-assessed sense of energy were recorded at 
the time of each test. Reaction time for Digit-Symbol 
Substitution Test (DSST) increased, delayed memory was 
degraded, MAP and energy level decreased, and heart rate 
increased (all p < 0.05). Increasing PaO2 to 406 ± 47 mmHg 
reversed the DSST result and the delayed memory changes 
to values not diﬀ   erent from those at the baseline Hb 
concentration of 12.7 ± 1.0 g/dl, and decreased heart rate 
(p < 0.05) although MAP and energy level changes were 
not altered with increased PaO2 during acute anemia. In 
that study, the authors conﬁ  rmed that acute isovolemic 
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increases heart rate, and decreases energy levels [14].
Subsequent studies identiﬁ  ed the cause of the observed 
cognitive function deﬁ  cits in impaired central processing 
as quantiﬁ  ed by measurement of the P300 latency. Th  e  P300 
response was signiﬁ   cantly prolonged when unmedi  cated 
healthy volunteers were hemodiluted from hemo  globin 
concentrations of 12.4 ± 1.3 to 5.1 ± 0.2 g/dl [15]. Th  e 
increased P300 latencies could be reversed to values not 
signiﬁ  cantly diﬀ  erent from baseline when inspired oxygen 
concentration was increased from 21 (room air) to 100%. 
Th   ese results suggest that P300 latency is a variable that is 
sensitive enough to predict subtle changes in cognitive 
function. Accordingly, increase in the P300 latency above a 
certain threshold may serve as a monitor of inadequate 
cerebral oxygenation and as an organ-speciﬁ  c transfusion 
trigger in the future. Spahn and Madjdpour recently 
commented [16] that Weiskopf et al. [15, 17] have opened 
a “window to the brain” with respect to monitoring the 
adequacy of cerebral oxygenation during acute anemia.
Th   ese observations and results clearly indicate that there 
is no ‘universal’ Hb threshold that could serve as a reliable 
transfusion trigger and that transfusion guide  lines should 
take into account the patient’s individual ability to tolerate 
and to compensate for the acute decrease in Hb 
concentration. Useful transfusion triggers should rather 
consider signs of inadequate tissue oxygenation that may 
occur at various hemoglobin concentrations depending on 
the patient’s underlying disease(s) [18].
Conclusion
Physiologic transfusion triggers should progressively 
replace arbitrary Hb-based transfusion triggers [19]. Th  e 
same conclusions were drawn by Orlov et al. in a recent 
trial using a global oxygenation parameter for guiding RBC 
transfusion in cardiac surgery [20]. Th  e use of goal-
directed erythrocyte transfusions should render the 
manage  ment of allogeneic red cell use more eﬃ   cient and 
should help: 1) in saving blood and avoiding unwanted 
adverse eﬀ  ects; and 2) in promoting and optimizing the 
adequacy of this life-saving treatment [16]. Th  ese 
‘physiologic’ transfusion triggers can be based on signs and 
symptoms of impaired global (lactate, SvO2 or ScvO2) or, 
even better, regional tissue (EKG ST-segment, DSST or 
P300 latency) oxygenation; they do, however, have to 
include two important simple hemodynamic targets: heart 
rate and MAP or systolic arterial pressure.
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